Should women with early breast cancer under 40 years of age have a routine 21-gene recurrence score testing: A SEER database study

PURPOSE: To investigate the effect of 21-gene recurrence score (RS) on chemotherapy-decision making and prognosis in breast cancer patients aged <40 years. METHODS: Using the Surveillance, Epidemiology, and End Results program, we included patients aged <40 years with tumor size ≤5 cm, node ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kai-Hua, Zhang, Lei, Chen, Jian-Xian, Lian, Chen-Lu, Wang, Jun, He, Zhen-Yu, Wu, San-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375685/
https://www.ncbi.nlm.nih.gov/pubmed/31918322
http://dx.doi.org/10.1016/j.breast.2019.12.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375685/
https://www.ncbi.nlm.nih.gov/pubmed/31918322
http://dx.doi.org/10.1016/j.breast.2019.12.013

Ejemplares similares